SCHEMBL21453931

SCHEMBL21453931

c1ccc(N2c3ccccc3C3(c4ccccc42)c2ccccc2N(c2ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc2)c2ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ATM Q13315 1/20 0.46
HDAC4 P56524 1/20 0.39
TSPO P30536 1/20 0.34
PTGER4 P35408 1/20 0.33
EDNRA P25101 2/20 0.33
EDNRB P24530 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.32
IL1R1 P14778 1/20 0.32
KDR P35968 1/20 0.32
MAPK8 P45983 1/20 0.32
MAPK9 P45984 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
AKR1C4 P17516 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19054974 0.95 KDM4E (0.42) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL17197573 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL25061381 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL25061399 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL17197574 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL12126523 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL12126521 0.91 KDM4E (0.43) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL12334196 0.91 KDM4E (0.38) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL21888172 0.91 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4TSPO
SCHEMBL10309960 0.91 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLCO2A1, SLCO1A2 L3MBTL1 2377/4885KDM4E 3411/4885ATM 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.